Results: 4

Desensibilización a pirfenidona. Caso clínico

Rev. méd. Chile; 149 (10), 2021
We report a 68-year-old woman with a history of idiopathic pulmonary fibrosis, who had immediate skin reactions associated with the use of pirfenidone in two opportunities. In the evaluation by immunology, an allergy to pirfenidone was diagnosed. Given the urgent need for the drug, a desensitization proc...

Trametinib and dabrafenib induced rhabdomyolysis, renal failure, and visual loss. Report of one case

Rev. méd. Chile; 148 (11), 2020
ABSTRACT MEK- and BRAF-inhibitors trametinib and dabrafenib are successfully used for BRAF-mutated, metastasizing melanoma, but these compounds may induce side effects. We report a 50 years old female with BRAF-mutated metastasizing melanoma who received trametinib (2 mg/d) and dabrafenib (200 mg/d) afte...

Manejo de hemorragia asociada a anticoagulantes orales directos: estado actual de las estrategias de reversión

Rev. méd. Chile; 147 (1), 2019
Direct oral anticoagulants (DOACs), including the direct thrombin inhibitor dabigatran and the direct factor Xa inhibitors rivaroxaban, apixaban and edoxaban have at least comparable efficacy as vitamin K antagonists along with a better safety profile, reflected by a lower incidence of intracranial hemor...

El apixaban se asocia a un menor riesgo de sangrado que los antagonistas de la vitamina K
Apixaban is associated with a lower risk of bleeding than vitamin K antagonists